Complex III Inhibition-Induced Pulmonary Hypertension Affects the Mitochondrial Proteomic Landscape.

TitleComplex III Inhibition-Induced Pulmonary Hypertension Affects the Mitochondrial Proteomic Landscape.
Publication TypeJournal Article
Year of Publication2020
AuthorsJames J, Varghese MValuparamp, Vasilyev M, Langlais PR, Tofovic SP, Rafikova O, Rafikov R
JournalInt J Mol Sci
Volume21
Issue16
Date Published2020 Aug 08
ISSN1422-0067
KeywordsAnimals, Electron Transport Complex III, Fatty Acids, Female, Hypertension, Pulmonary, Mitochondria, Models, Biological, Proteome, Proteomics, Rats
Abstract

The mitochondria play a vital role in controlling cell metabolism and regulating crucial cellular outcomes. We previously demonstrated that chronic inhibition of the mitochondrial complex III in rats by Antimycin A (AA) induced sustained pulmonary vasoconstriction. On the metabolic level, AA-induced mitochondrial dysfunction resulted in a glycolytic shift that was reported as the primary contributor to pulmonary hypertension pathogenesis. However, the regulatory proteins driving this metabolic shift with complex III inhibition are yet to be explored. Therefore, to delineate the mechanisms, we followed changes in the rat lung mitochondrial proteome throughout AA treatment. Rats treated with AA for up to 24 days showed a disturbed mitochondrial proteome with significant changes in 28 proteins (

DOI10.3390/ijms21165683
Alternate JournalInt J Mol Sci
PubMed ID32784406
PubMed Central IDPMC7461049
Grant ListR01HL133085 / HL / NHLBI NIH HHS / United States
R01HL151447 / HL / NHLBI NIH HHS / United States
R01 HL151447 / HL / NHLBI NIH HHS / United States
R01 HL132918 / HL / NHLBI NIH HHS / United States
R01HL132918 / HL / NHLBI NIH HHS / United States